Purchases and Sales Made in Q3 2024 in Indaptus Therapeutics, Inc. (INDP)
This table provides information about the institutional ownership of Indaptus Therapeutics, Inc. (INDP) during Q3 2024. The information is specifically focused on institutions that hold shares of Indaptus Therapeutics, Inc..
| Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
|---|---|---|---|---|---|---|---|
|
Nov 12, 2024
Q3 2024
|
Geode Capital Management, LLC
Boston, MA |
BUY
|
- |
13.8K+ 23.3% |
$15.6K - $31.1K
|
73.1K
$71.7K
|
|
|
Nov 14, 2024
Q3 2024
|
Tower Research Capital LLC (Trc)
New York, NY |
BUY
|
- |
710+ 17.31% |
$802 - $1.6K
|
4.81K
$4.72K
|
|
|
Nov 13, 2024
Q3 2024
|
Jim Simons
Renaissance Technologies LLC | New York, Ny
|
BUY
|
- |
500+ 1.88% |
$565 - $1.13K
|
27.1K
$26.6K
|
|
|
Nov 14, 2024
Q3 2024
|
Bank Of America Corp
Charlotte, NC |
BUY
|
- |
18+ 42.86% |
$20.3 - $40.5
|
60
$58.8
|
|
|
Nov 08, 2024
Q3 2024
|
Jpmorgan Chase & CO
New York, NY |
BUY
|
- |
4+ 26.67% |
$4.52 - $9
|
19
$18.6
|
|
|
Oct 10, 2024
Q3 2024
|
Concourse Financial Group Securities, Inc.
Birmingham, AL |
BUY
|
- |
0New |
$0 - $0
|
0
$0
|
|
|
Nov 25, 2024
Q3 2024
|
Pine Valley Investments LTD Liability CO
Marlton, NJ |
SELL
|
- |
-102- 0.23% |
$115 - $230
|
44K
$43.1K
|
|
|
Nov 14, 2024
Q3 2024
|
Ubs Group Ag
|
SELL
|
- |
-170- 24.57% |
$192 - $383
|
522
$512
|
|
|
Nov 07, 2024
Q3 2024
|
Investment House LLC
Las Vegas, NV |
SELL
|
- |
-2.46K- 2.4% |
$2.78K - $5.54K
|
100K
$98K
|
|
|
Nov 14, 2024
Q3 2024
|
Ken Griffin
Citadel Advisors LLC | Chicago, Il
|
SELL
|
- |
-6.82K- 30.71% |
$7.71K - $15.3K
|
15.4K
$15.1K
|